SP
Sangita Paul
About Sangita Paul
Data last updated:
Sangita Paul has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Duckbill Drugs Pvt Ltd. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Duckbill Drugs Pvt Ltd at ₹7.20 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Duckbill Drugs Pvt Ltd U24232WB1994PTC063258 | Director | 30 Mar 2023 | 1994 | ₹7.20 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sangita Paul
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sangita Paul
Sangita Paul has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Duckbill Drugs Pvt Ltd. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Duckbill Drugs Pvt Ltd at ₹7.20 Cr (FY 2025).
Sangita Paul is associated with 1 company as Director, including Duckbill Drugs Pvt Ltd (₹7.20 Cr).
Sangita Paul has expertise in General Business.
Sangita Paul has 3 years in corporate governance.
By reported revenue, the largest current company of Sangita Paul is Duckbill Drugs Pvt Ltd, with revenue of ₹7.20 Cr (FY 2025).
Sangita Paul currently holds positions at 1 company: Duckbill Drugs Pvt Ltd (₹7.20 Cr).